Effects of far infrared therapy on arteriovenous fistulas in hemodialysis patients: a meta-analysis

Wan, Qingsong; Yang, Shikun; Li, Li; Chu, Fenfen

doi:10.1080/0886022x.2017.1361835

Cited by 25 publications

(25 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Chapter 8 covers longterm patency of AV fistulas and AV grafts. We identified seven systematic reviews of RCTs assessing benefits and harms of various medical adjuvant treatments to increase overall patency of AV fistulas and AV grafts [13][14][15][16][17][18][19]. All these reviews were judged to be of moderate to high quality with AMSTAR scores of 8-10/11.…”

Section: Rationale • Backgroundmentioning

confidence: 99%

Clinical practice guideline on peri- and postoperative care of arteriovenous fistulas and grafts for haemodialysis in adults

Gallieni

Hollenbeck

Inston

et al. 2019

Nephrology Dialysis Transplantation

106

View full text Add to dashboard Cite

Chapter 2. Surgical and endovascular interventions for promoting arteriovenous fistula maturation 2.1. We suggest using regional block anaesthesia rather than local anaesthesia for arteriovenous fistula creation in adults with end-stage kidney disease. (2C) 2.2. We suggest there is insufficient evidence to support endof-vein to side-of-artery over side-of-vein to side-ofartery anastomosis for arteriovenous fistula creation in adults with end-stage kidney disease (2C) peri-and postoperative care of AV fistulas and grafts ii3

show abstract

Section: Rationale • Backgroundmentioning

confidence: 99%

Clinical practice guideline on peri- and postoperative care of arteriovenous fistulas and grafts for haemodialysis in adults

Gallieni

Hollenbeck

Inston

et al. 2019

Nephrology Dialysis Transplantation

106

View full text Add to dashboard Cite

show abstract

“…FIT applied for 40 min three times a week for 12 months, resulted in lower rates of AVF malfunction (thrombosis or requirement of intervention) compared with placebo (12% vs 29% respectively p = 0.02), higher maturation rates (82% vs 60% p = 0.008), and higher rates of cumulative unassisted AVF patency (87% vs 70% p = 0.01) at 12 months [115]. A subsequent meta-analysis of RCTs and quasi-RCTs by Wan et al [131] [131]. The quality of evidence provided in this meta-analysis is limited by small-scale studies of short duration (maximum 12 months).…”

Section: Far Infrared Therapymentioning

confidence: 97%

Pathogenesis and Prevention of Vascular Access Failure

Hudson¹,

Johnson²,

Viecelli³

2019

Vascular Access Surgery - Tips and Tricks

View full text Add to dashboard Cite

Dialysis vascular access failure is common, is rated as a critical priority by both patients and health professionals, and is associated with excess morbidity, mortality and healthcare costs. This chapter will discuss the mechanisms underpinning vascular access failure as well as strategies for preventing this adverse outcome, including systemic medical therapies (such as antiplatelet agents, fish oils, statins, inhibitors of the renin-angiotensin-aldosterone system, and calcium channel blockers), and local therapeutic interventions including innovative surgical techniques, minimally invasive AVF creation, far infra-red therapy, perivascular application of recombinant elastase, endothelial loaded gel foam wrap (Vascugel), and antiproliferative agents such as sirolimus (Coll-R) and paclitaxel-coated balloon angioplasty.

show abstract

“…192 In addition, the use of infrared radiation therapy has been reported to improve AVF maturation and primary and secondary patency rates by inhibiting intimal hyperplasia, reducing oxidative stress and inflammation and improving endothelial function. [174][175][176][177][178]193 Although new preventive and therapeutic approaches are in development and aimed at targeting certain mechanisms associated with AVF dysfunction, in order to promote outward remodelling and inhibit NIH formation, a multi-target approach is necessary, considering the complexity of this pathogenic process. Thus, an effective approach to VA comprises patient selection, surgical method of AVF creation, prevention, surveillance and treatment of AVF dysfunction.…”

Section: Improving Va Outcomesmentioning

confidence: 99%

Factors affecting arteriovenous fistula dysfunction: A narrative review

Gameiro

Ibeas

2019

J Vasc Access

View full text Add to dashboard Cite

Vascular access dysfunction is one of the most important causes of morbidity and mortality in haemodialysis patients, contributing to up to one third of hospitalisations and accounting for a significant amount of the health care costs of these patients. In the past decades, significant scientific advances in understanding mechanisms of arteriovenous fistula maturation and failure have contributed to an increase in the amount of research into techniques for creation and strategies for arteriovenous fistula dysfunction prevention and treatment, in order to improve patient care and outcomes. The aim of this review is to describe the pathogenesis of vascular access failure and provide a comprehensive analysis of the associated risk factors and causes of vascular access failure, in order to interpret possible future therapeutic approaches. Arteriovenous fistula failure is a multifactorial process resulting from the combination of upstream and downstream events with consequent venous neo-intimal hyperplasia and/or inadequate outward remodelling. Inflammation appears to be central in the biology of arteriovenous fistula dysfunction but important triggers still need to be revealed. Given the significant association of arteriovenous fistula failure and patient’s prognosis, it is therefore imperative to further research in this area in order to improve prevention, surveillance and treatment, and ultimately patient care and outcomes.

show abstract

Effects of far infrared therapy on arteriovenous fistulas in hemodialysis patients: a meta-analysis

Abstract: FIR therapy can reduce AVFs occlusion rates and needling pain level, while significantly improve the level of vascular access blood flow, AVFs diameter and the primary AVFs patency.

Cited by 25 publications

References 23 publications

Clinical practice guideline on peri- and postoperative care of arteriovenous fistulas and grafts for haemodialysis in adults

Clinical practice guideline on peri- and postoperative care of arteriovenous fistulas and grafts for haemodialysis in adults

Pathogenesis and Prevention of Vascular Access Failure

Factors affecting arteriovenous fistula dysfunction: A narrative review

Contact Info

Product

Resources

About